188 related articles for article (PubMed ID: 10051147)
1. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
2. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors.
Gotti C; Balestra B; Moretti M; Rovati GE; Maggi L; Rossoni G; Berti F; Villa L; Pallavicini M; Clementi F
Br J Pharmacol; 1998 Jul; 124(6):1197-206. PubMed ID: 9720791
[TBL] [Abstract][Full Text] [Related]
3. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
4. Effects of Zn2+ on wild and mutant neuronal alpha7 nicotinic receptors.
Palma E; Maggi L; Miledi R; Eusebi F
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10246-50. PubMed ID: 9707632
[TBL] [Abstract][Full Text] [Related]
5. Alpha-conotoxins PnIA and [A10L]PnIA stabilize different states of the alpha7-L247T nicotinic acetylcholine receptor.
Hogg RC; Hopping G; Alewood PF; Adams DJ; Bertrand D
J Biol Chem; 2003 Jul; 278(29):26908-14. PubMed ID: 12746432
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical allosteric effects of competitive inhibitors on neuronal alpha7 nicotinic receptor mutants.
Bertrand S; Devillers-Thiéry A; Palma E; Buisson B; Edelstein SJ; Corringer PJ; Changeux JP; Bertrand D
Neuroreport; 1997 Nov; 8(16):3591-6. PubMed ID: 9427332
[TBL] [Abstract][Full Text] [Related]
7. Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers.
López MG; Montiel C; Herrero CJ; García-Palomero E; Mayorgas I; Hernández-Guijo JM; Villarroya M; Olivares R; Gandía L; McIntosh JM; Olivera BM; García AG
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14184-9. PubMed ID: 9826675
[TBL] [Abstract][Full Text] [Related]
8. Properties of neuronal alpha7 mutant nicotinic acetylcholine receptors gated by bicuculline.
Tonini R; Palma E; Miledi R; Eusebi F
Neuropharmacology; 2003 May; 44(6):765-71. PubMed ID: 12681375
[TBL] [Abstract][Full Text] [Related]
9. A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.
Hone AJ; Whiteaker P; Christensen S; Xiao Y; Meyer EL; McIntosh JM
J Neurochem; 2009 Oct; 111(1):80-9. PubMed ID: 19650873
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nicotinic acetylcholine receptors by bicuculline.
Demuro A; Palma E; Eusebi F; Miledi R
Neuropharmacology; 2001 Dec; 41(7):854-61. PubMed ID: 11684149
[TBL] [Abstract][Full Text] [Related]
11. Strychnine activates neuronal alpha7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains.
Palma E; Fucile S; Barabino B; Miledi R; Eusebi F
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13421-6. PubMed ID: 10557336
[TBL] [Abstract][Full Text] [Related]
12. Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.
Palma E; Mileo AM; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11231-5. PubMed ID: 8855338
[TBL] [Abstract][Full Text] [Related]
13. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of the neuronal alpha7 and L247T alpha7 mutant subunits yields hybrid nicotinic receptors with properties of both wild-type alpha7 and alpha7 mutant homomeric receptors.
Palma E; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1539-43. PubMed ID: 9037089
[TBL] [Abstract][Full Text] [Related]
15. Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.
Fucile S; Palma E; Eusebi F; Miledi R
Neuroscience; 2002; 110(1):169-79. PubMed ID: 11882381
[TBL] [Abstract][Full Text] [Related]
16. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
Liu Q; Huang Y; Xue F; Simard A; DeChon J; Li G; Zhang J; Lucero L; Wang M; Sierks M; Hu G; Chang Y; Lukas RJ; Wu J
J Neurosci; 2009 Jan; 29(4):918-29. PubMed ID: 19176801
[TBL] [Abstract][Full Text] [Related]
17. Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant.
Briggs CA; McKenna DG; Monteggia LM; Touma E; Roch JM; Arneric SP; Gopalakrishnan M; Sullivan JP
Eur J Pharmacol; 1999 Feb; 366(2-3):301-8. PubMed ID: 10082212
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
Tanibuchi Y; Wu J; Toyohara J; Fujita Y; Iyo M; Hashimoto K
Brain Res; 2010 Aug; 1348():200-8. PubMed ID: 20537987
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists.
López-Hernández GY; Thinschmidt JS; Zheng G; Zhang Z; Crooks PA; Dwoskin LP; Papke RL
Mol Pharmacol; 2009 Sep; 76(3):652-66. PubMed ID: 19556356
[TBL] [Abstract][Full Text] [Related]
20. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
